九强生物：关于非独立董事辞职暨选举职工代表董事及补选董事会专门委员会委员的公告

Core Points - Jiukang Bio announced the resignation of non-independent director Liu Xi due to adjustments in the company's governance structure [2] - Liu Xi will continue to hold other positions within the company after his resignation [2] - On November 14, 2025, the company held a staff representative meeting where Liu Xi was elected as a representative director of the fifth board of directors [2] - The term for Liu Xi as a representative director will last until the end of the fifth board's term [2] - The company also held the 12th meeting of the fifth board of directors on the same day, approving the election of new members for the specialized committees [2] Committee Restructuring - The Strategic Committee now includes Zou Zuojun (convener), Wang Yongli, Liu Xi, Luo Aiping, and Yang Jianping [2] - The Audit Committee is composed of Chen Yonghong (convener), Ye Jun, and Sun Xiaolin [2] - The Nomination Committee consists of Yang Jianping (convener), Chen Yonghong, and Wang Xiaoya [2] - The Compensation and Assessment Committee includes Ye Jun (convener), Chen Yonghong, and Liu Xi [2]